Literature DB >> 20228226

Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.

Yoshihide Asano1, Lukasz Stawski, Faye Hant, Kristin Highland, Richard Silver, Gabor Szalai, Dennis K Watson, Maria Trojanowska.   

Abstract

Systemic sclerosis or scleroderma (SSc) is a complex autoimmune connective tissue disease characterized by obliterative vasculopathy and tissue fibrosis. The molecular mechanisms underlying SSc vasculopathy are largely unknown. Friend leukemia integration factor 1 (Fli1), an important regulator of immune function and collagen fibrillogenesis, is expressed at reduced levels in endothelial cells in affected skin of patients with SSc. To develop a disease model and to investigate the function of Fli1 in the vasculature, we generated mice with a conditional deletion of Fli1 in endothelial cells (Fli1 CKO). Fli1 CKO mice showed a disorganized dermal vascular network with greatly compromised vessel integrity and markedly increased vessel permeability. We show that Fli1 regulates expression of genes involved in maintaining vascular homeostasis including VE-cadherin, platelet endothelial cell adhesion molecule 1, type IV collagen, matrix metalloproteinase 9, platelet-derived growth factor B, and S1P(1) receptor. Accordingly, Fli1 CKO mice are characterized by down-regulation of VE-cadherin and platelet endothelial cell adhesion molecule 1, impaired development of basement membrane, and a decreased presence of alpha-smooth muscle actin-positive cells in dermal microvessels. This phenotype is consistent with a role of Fli1 as a regulator of vessel maturation and stabilization. Importantly, vascular characteristics of Fli1 CKO mice are recapitulated by SSc microvasculature. Thus, persistently reduced levels of Fli1 in endothelial cells may play a critical role in the development of SSc vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228226      PMCID: PMC2843486          DOI: 10.2353/ajpath.2010.090593

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  VE-cadherin is a critical endothelial regulator of TGF-beta signalling.

Authors:  Noemi Rudini; Angelina Felici; Costanza Giampietro; MariaGrazia Lampugnani; Monica Corada; Kendra Swirsding; Massimiliano Garrè; Stefan Liebner; Michelle Letarte; Peter ten Dijke; Elisabetta Dejana
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

2.  Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation.

Authors:  Yoshihide Asano; Joanna Czuwara; Maria Trojanowska
Journal:  J Biol Chem       Date:  2007-09-19       Impact factor: 5.157

Review 3.  The pericyte: cellular regulator of microvascular blood flow.

Authors:  Matthew E Kutcher; Ira M Herman
Journal:  Microvasc Res       Date:  2009-02-07       Impact factor: 3.514

4.  Vascular normalization in Rgs5-deficient tumours promotes immune destruction.

Authors:  Juliana Hamzah; Manfred Jugold; Fabian Kiessling; Paul Rigby; Mitali Manzur; Hugo H Marti; Tamer Rabie; Sylvia Kaden; Hermann-Josef Gröne; Günter J Hämmerling; Bernd Arnold; Ruth Ganss
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

5.  Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5.

Authors:  Andrea Taddei; Costanza Giampietro; Annarita Conti; Fabrizio Orsenigo; Ferruccio Breviario; Valentina Pirazzoli; Michael Potente; Christopher Daly; Stefanie Dimmeler; Elisabetta Dejana
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

6.  Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.

Authors:  Graeme M Birdsey; Nicola H Dryden; Valerie Amsellem; Frank Gebhardt; Kapil Sahnan; Dorian O Haskard; Elisabetta Dejana; Justin C Mason; Anna M Randi
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

7.  Fli1 acts at the top of the transcriptional network driving blood and endothelial development.

Authors:  Feng Liu; Maggie Walmsley; Adam Rodaway; Roger Patient
Journal:  Curr Biol       Date:  2008-08-26       Impact factor: 10.834

8.  The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice.

Authors:  Xian K Zhang; Omar Moussa; Amanda LaRue; Sarah Bradshaw; Ivan Molano; Demetri D Spyropoulos; Gary S Gilkeson; Dennis K Watson
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

9.  Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.

Authors:  Yoshihide Asano; Margaret Markiewicz; Masahide Kubo; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

10.  Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

Authors:  Jo N Fleming; Richard A Nash; D O McLeod; David F Fiorentino; Howard M Shulman; M Kari Connolly; Jerry A Molitor; Gretchen Henstorf; Robert Lafyatis; David K Pritchard; Lawrence D Adams; Daniel E Furst; Stephen M Schwartz
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

View more
  69 in total

Review 1.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

Review 2.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

Review 3.  Update on macrophages and innate immunity in scleroderma.

Authors:  Jennifer J Chia; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

4.  Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy.

Authors:  Takashi Yamashita; Yoshihide Asano; Ryosuke Saigusa; Takashi Taniguchi; Megumi Hirabayashi; Takuya Miyagawa; Kouki Nakamura; Shunsuke Miura; Ayumi Yoshizaki; Maria Trojanowska; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2018-11-30       Impact factor: 8.551

Review 5.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

Review 6.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 7.  Fibrogenesis, novel lessons from animal models.

Authors:  Ellen De Langhe; Rik Lories
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

8.  Linking Vascular Remodeling and Inflammation in Pulmonary Arterial Hypertension: Is There a Common Root Cause?

Authors:  Patricia A Thistlethwaite
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

9.  The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.

Authors:  Lukasz Stawski; Grace Marden; Maria Trojanowska
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

10.  Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA.

Authors:  Robert D Bell; Xiaochun Long; Mingyan Lin; Jan H Bergmann; Vivek Nanda; Sarah L Cowan; Qian Zhou; Yu Han; David L Spector; Deyou Zheng; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-27       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.